On the stock market since 2025, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
The stock trades 34% below its peak. The market has trimmed its expectations for the company.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
A loss of $24K against $0 in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, CCCM sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CCCM is a high-risk stock — not yet profitable, and its future rides on its product catching on.